Weight stabilizes after 8–12 months on semaglutide at ~16% loss, but patients regain 63–74% of lost weight after stopping — complicating body contouring surgery timing.
63–74% of weight regainedAfter stopping semaglutide, patients regained most of their lost weight within months — a critical consideration for anyone planning body contouring surgery after GLP-1 weight loss.
What the researchers found
Weight loss on semaglutide plateaus at approximately 53 weeks (about 12 months) of treatment, with patients losing an average of 16% body weight. This plateau deviated from the greatest on-treatment weight loss by only 2%, suggesting stable weight is achieved around the 8–12 month mark — the point at which body contouring surgery may be appropriate.
However, the review also found a major concern: after stopping semaglutide, patients regained 62.7% to 74.3% of their greatest on-treatment weight loss. Weight recurrence (defined as regaining ≥25% of lost weight) occurred as early as 12 weeks after discontinuation. This massive weight regain raises serious questions about the durability of surgical outcomes if patients stop the drug after body contouring.
Why it matters
As millions of people lose significant weight on semaglutide (Ozempic/Wegovy), demand for body contouring surgery to remove excess skin has surged — a phenomenon dubbed the 'Ozempidemic' in plastic surgery. This review provides the first evidence-based timing guidance, but also sounds a warning: unlike bariatric surgery weight loss (which is largely permanent), semaglutide weight loss reverses substantially after stopping the drug. Surgeons and patients need to plan accordingly.
How the study worked
Systematic review and meta-analysis of MEDLINE, Embase, Web of Science, and PubMed. From 555 identified studies, 12 RCTs and prospective observational studies met inclusion criteria, encompassing 13,947 patients. The researchers calculated time to weight loss plateau (defined as ≥1 month with <3% weight loss) and weight recurrence rates after drug discontinuation.
Who was studied
13,947 patients across 12 studies (RCTs and prospective observational studies) using semaglutide for weight loss
What this study cannot tell us
Only 2 of the 12 included studies assessed weight recurrence after drug discontinuation, limiting confidence in the weight regain estimates. The review focused on semaglutide specifically — results may differ for tirzepatide or other GLP-1 drugs. Long-term outcomes of body contouring surgery performed during or after GLP-1 therapy have not yet been studied directly.
How to read the evidence
This is a systematic review and meta-analysis of 12 studies including RCTs, representing strong evidence for weight loss trajectory timing. However, only 2 studies assessed weight regain after discontinuation, making that specific finding less robust.
When this study was published
Published in 2025, this is one of the first systematic reviews addressing the intersection of GLP-1 weight loss and plastic surgery — a rapidly emerging clinical question.
The bigger picture
The explosion of GLP-1 drug use for weight loss has created an entirely new patient population seeking plastic surgery — people who've lost substantial weight without surgery but now have excess skin. Unlike bariatric surgery patients (who have decades of surgical outcome data), GLP-1 weight loss patients represent uncharted territory for plastic surgeons. This review is among the first to provide evidence-based guidance, but the weight regain data introduces a fundamental question the field hasn't faced before: should body contouring be performed while patients stay on the drug indefinitely?
Questions still open
- Should patients stay on semaglutide indefinitely to protect body contouring surgical results?
- How does weight regain after GLP-1 discontinuation specifically affect body contouring outcomes like skin laxity recurrence?
- Does tirzepatide (which may cause greater weight loss) have a different timeline for weight stabilization?
Common questions
How long should you wait after starting semaglutide before getting body contouring surgery?
What happens to body contouring results if you stop taking semaglutide?
Read the original research
Plastic Surgery in the Ozempidemic: Considerations for the Timing of Body Contouring Surgery in Patients with Semaglutide-Associated Weight Loss.
Aesthetic plastic surgery, 49(21), 6078-6088
Citation
Garbaccio, Noelle C; Smith, Jade E; Posso, Agustin; Schonebaum, Dorien I; Foster, Lacey; Cordero, Justin J; Foppiani, Jose; Alvarez, Angelica Hernandez; Choudry, Umar; Lin, Samuel J. (2025). Plastic Surgery in the Ozempidemic: Considerations for the Timing of Body Contouring Surgery in Patients with Semaglutide-Associated Weight Loss.. Aesthetic plastic surgery, 49(21), 6078-6088. https://doi.org/10.1007/s00266-025-05112-3